Sign in

Jennifer A. Marks, MD

@jennifermarksmd.bsky.social
583 followers 704 following 32 posts

#Thoracic #Oncologist 🫁 @DanaFarber @HarvardMed |@LombardiCancer @EmoryDeptofMed @GradyHealth @tulanemedicine | #MedEd #medsky |🐱mom| she/her ⚜️viewsmyown #lcsm #thymic

PostsRepliesMedia
Reposted by Jennifer A. Marks, MD
D. Ross Camidge @drcamidge.bsky.social · 22/02/2026
At last week’s lung cancer conference I went full public with my dual role as patient and expert. I spoke after Jane Perlmutter a four time survivor (middle). Both of us were introduced by Dr Shirish Gadgeel- Jane’s doctor and my friend.
1102
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 21/01/2026
New lung cancer research insights 🎥 In this expert roundtable led by Dr. @jennifermarksmd, Dr. Elliot Brea shares ASCO 2025 updates on emerging cellular therapies, including CAR T-cell therapy, for NSCLC and SCLC—explained clearly and concisely. Watch the full video: youtu.be/hLy10mitvG8
022
Reposted by Jennifer A. Marks, MD
D. Ross Camidge @drcamidge.bsky.social · 28/11/2025
Recently live: How this is building me - Me and Blumenthal. podcasts.apple.com/us/podcast/h...
podcasts.apple.com
How An Interest in Translational Research and Drug Development Helps Evolve Regulatory Practices: With D. Ross Camidge, MD, PhD; and Gideon Blumenthal, MD
Podcast Episode · How This Is Building Me · 11/26/2025 · 55m
131
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 08/12/2025
Great to share lung cancer research updates with colleagues and friends at the 2025 IASLC NACLC meeting Thank you to chairs Drs. Bestvina, Marrone, Rengan and Gillaspie for organizing an energizing and fun conference @iaslc.bsky.social @danafarber.bsky.social #NACLC25
182
Reposted by Jennifer A. Marks, MD
D. Ross Camidge @drcamidge.bsky.social · 08/09/2025
After three years I feel ready to enter a new phase of patient empowerment by publicly disclosing my own disgnosis. This went live today and all good. news.cuanschutz.edu/cancer-cente...
news.cuanschutz.edu
World Lung Cancer Expert Diagnosed with Advanced Lung Cancer
D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, that fight turned personal when he received a diagnosis of his own.
102710
Jennifer A. Marks, MD @jennifermarksmd.bsky.social · 07/08/2025
😭😭😭
010
Reposted by Jennifer A. Marks, MD
BK. Titanji @boghuma.bsky.social · 11/07/2025
Rolling back vaccine access while expanding unwarranted access to over the counter ivermectin is proof that we are living in a most idiotic timeline.
2721649
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 04/04/2025
A season of celebration - huge congratulations to superstar mentees who will be moving on to new adventures, including UCLA med and Harvard med!! The future is bright!
142
Reposted by Jennifer A. Marks, MD
Estelamari Rodríguez @latinamd.bsky.social · 07/04/2025
#ASCOAdvocacySummit starting today with remarks by @RepHerbConaway MD. Honored to be here representing FL oncologists to advocate for issues that impact our patients and field. #patientadvocacy @ascocancer.bsky.social @sylvestercancer
021
Jennifer A. Marks, MD @jennifermarksmd.bsky.social · 03/04/2025
A little rhythm tap for that serotonin boost #umbrella #jukeboxtour #tap #1940s m.youtube.com/watch?v=OBml...
m.youtube.com
Umbrella - Vintage "Singin' in the Rain" Style Rihanna Cover ft. Casey Abrams & The Sole Sisters
YouTube video by PostmodernJukebox
020
Reposted by Jennifer A. Marks, MD
Yvonne Diaz @yvonnediaz.bsky.social · 16/03/2025
We patients often wonder why each of us responds so individually to our targeted therapies. It’s heartbreaking when you see up close how not all derive the same benefit from the exact same drug w seemingly the same disease. Important to understand what factor influence this & do something about it.
031
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Dr. @LeXiuning now presenting #EGFR and #HER2 targeted therapies -new development and changing landscapes at our Targeted Therapies in Lung Cancer Live event! #TargetedTherapies #LungCancer #Flaura2 #Osimeritinib
022
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
• If you smoke, quit. Your risk of cancer starts coming down about two years. • Quitting is hard…..so try again! • Nicotine replacement (gum, patches, or vape) is better than smoking. Amazing presentation Dr. Jorge Nieva!
022
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Dr. Jorge Nieva now presenting #KRAS and #BRAF. What is signaling? Why do mutations in KRAS and BRAF mess it up? #TargetedTherapiesInLungCancer #LungCancer
021
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Amazing presentation of Dr. @ADesaiMD about NTRK (Neurotrophic Tyrosine Receptor Kinase). Join us now at live.classy.org/register/ttl... #MET #NTRK #NRG1 #NSCLC
021
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Happening now! Dr. Aakash Desai, MD, MPH talking about MET, NTRK and NRG1 driven NSCLC. What is #MET?
032
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
What is Rearranged during Transfection? By Dr. @ChristineBestv1 at our Targeted Therapies in Lung Cancer Event. #RET #LungCancer #TargetedTherapies #RETFussion
042
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Dr. @ChristineBestv1 now presenting: ALK, ROS1 and RET: Pushing the Boundaries of Targeted Therapies #ALK #ROS1 #RET #LungCancer #TargetedTherapies #cancerGRACE
186
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Q&A session with Drs. @lungoncdoc, @MMarmarelis, @LudaBazhenovaMD, and @IyengarPuneeth Can chemotherapy reset cancer? #CancerEducation #LungCancer #cancerGRACE #TargetedTherapiesInLungCancer
052
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Q&A session with Drs. @lungoncdoc, @MMarmarelis, @LudaBazhenovaMD, and @IyengarPuneeth Is it better to continue on the same therapy as long as possible? #TargetedTherapiesInLungCancer #LungCancer
054
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Dr. Puneeth Iyengar presenting live the Role of Radiation in Patients with Oncogenic Drivers. Click here to join us: live.classy.org/register/ttl...
042
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
What types of Targeted Therapies are there for NSCLC patients? By Dr. Melina Marmarelis #LungCancer #TargetedTherapiesinLungCancer #NSCLC
032
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Dr. Eric Singhi now live, presenting Understanding Resistance to Targeted Therapy in Non-Small Cell Lung Cancer. #TargetedTherapies #LungCancer #MolecularTesting #PersonalizedTreatment #NSCLC
052
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
What are some treatment strategies at time of progression? - Ask about Clinical Trials - Try to target specific mechanisms of resistance - "Standard of care" options Always advocated for yourself. Dr. Eric Singhi #LungCancerAdvocates #CancerCare #LungCancer #ClinicalTrials #Chemotherapy
042
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
What is cancer? By Dr. Triparna Sen #LungCancer #TargetedTherapies #TriparnaSen #CancerGRACE
021
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Dr. Melina Marmarelis presenting: What is Targeted Therapy? #TargetedTherapiesinLungCancer #LungCancer
032
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Dr. Karen Yun presenting: How Do You Read a Molecular Testing Report? What are Driver Alterations in Lung Cancer? #TargetedTherapiesInLungCancer #LungCancer #ALK #ROS1 #RET #NTRK #EGFR #BRAF #MET #HER2 #KRAS
074
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Next Generation Sequencing provides a comprehensive profile of tumor genetics. What are the pros and cons of #NGS? Join us at our Targeted Therapies in Lung Cancer If you want to learn more about NGS. We are live now! give.cancergrace.org/event/target...
032
Reposted by Jennifer A. Marks, MD
cancergrace @cancergrace.bsky.social · 15/03/2025
Now Dr. Jennifer Marks presenting Biomarker Testing 101 for Lung Cancer at our Targeted Therapies in Lung Cancer. What is a #biomarker? #ALk #ROS1 #LungCancer #TargetedTherapies #cancerGRACE #CancerEducation
021
Reposted by Jennifer A. Marks, MD
Yvonne Diaz @yvonnediaz.bsky.social · 15/03/2025
Great fishing 🎣 analogy from Dr @ludabazhenovamd.bsky.social on the use of liquid biopsies at the @cancergrace.bsky.social Patient Forum: If a liquid biopsy doesn’t turn up any biomarkers it doesn’t mean there aren’t any fish in the sea. Important to continue w tissue testing. #LCSM
052
Reposted by Jennifer A. Marks, MD
Jack West, MD, FASCO @jackwestmd.bsky.social · 15/03/2025
I didn't know Dr. Yun before today, but she raised at UCSD with Drs. Luda Bazhenova & Sandip Patel. She did a great job. Looking forward to seeing her career trajectory.
142
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 14/03/2025
Outstanding and inspiring talk by Dr Alice Shaw on 20+yr of multidisciplinary scientific collaborations to develop effective therapies for ALK+ lung cancers at the DFCI CCG Symposium @danafarber.bsky.social #lcsm #oncsky
031
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 12/03/2025
“As physicians, we are committed to finding treatments and cures. While we recognize the importance of directing more funding toward direct research costs, this policy carries unintended consequences that threaten the sustainability of U.S. biomedical research.”
022
Reposted by Jennifer A. Marks, MD
Tom Newsom-Davis @tnewsomdavis.bsky.social · 03/03/2025
Fantastic discussion of biomarkers for ADCs from Jan von der Thüsen 🔹 ORR with ADCs very variable 🔹 Relying on IHC may be problematic 🔹 Is a biomarker agnostic approach reasonable? 🔹 Could NMR be a solution, but it has its own challenges
073
Reposted by Jennifer A. Marks, MD
D. Ross Camidge @drcamidge.bsky.social · 03/03/2025
As the ASCO abstracts get reviewed for the June 2025 meeting around now. I wonder what the ISJET coubt will be? 😉 news.cuanschutz.edu/cancer-cente...
news.cuanschutz.edu
When ‘Acceptable’ is Unacceptable: A Call for Objectivity in Cancer Trial Results
CU Cancer Center member D. Ross Camidge, MD, PhD, has been to lots of scientific meetings over the years, and often he doesn’t like what he hears.
042
Jennifer A. Marks, MD @jennifermarksmd.bsky.social · 28/02/2025
youtu.be/QUQsqBqxoR4
youtu.be
Sara Bareilles - Brave (Official Video)
YouTube video by SaraBareillesVEVO
020
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 22/02/2025
Excellent summary of targeted therapies in clinical trials for mesothelioma, a thoracic malignancy without approved targeted agents by Dr Melina Marmarelis #TTLC25 @iaslc.bsky.social #lcsm
011
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 22/02/2025
Dr Mehmet Altan presenting on targeted therapies in clinical trials for thymic malignancies, emphasizing the importance of multicenter collaboration in this cancer #TTLC25 #lcsm @iaslc.bsky.social
011
Reposted by Jennifer A. Marks, MD
Gregory Riely @rielymd.bsky.social · 22/02/2025
Great talk by @jia-luo.bsky.social from @danafarber.bsky.social at #TTLC25 talking about NUT carcinoma also highlights recent review www.nature.com/articles/s41...
122
Reposted by Jennifer A. Marks, MD
Gregory Riely @rielymd.bsky.social · 22/02/2025
Important poster presented at #TTLC25 by @jessieross.bsky.social and Alissa Cooper from @mskcancercenter.bsky.social on overlap of DLL3/SEZ6 in high grade neuroendocrine cancers
0144
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 22/02/2025
Excellent talk and framework on the approach to targeted therapies for neuroendocrine tumors by Dr Nathaniel Myall #TTLC25 #lcsm @iaslc.bsky.social
031
Reposted by Jennifer A. Marks, MD
D. Ross Camidge @drcamidge.bsky.social · 21/02/2025
Targeted Therapies of Lung Cancer meeting 2025. Huntington Beach, California. Fish are fun, cherubs are wierd
1112
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 20/02/2025
Packed room at #TTLC25 and fantastic intro talk to EGFR therapy sequencing and unanswered questions by my colleague Dr Julia Rotow #lcsm #oncsky @danafarber.bsky.social @iaslc.bsky.social
173
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 20/02/2025
Excellent summary of the approach to uncommon EGFR mutations by Dr Xiuning Le (MDACC) #TTLC25 #lcsm #oncsky @iaslc.bsky.social
041
Reposted by Jennifer A. Marks, MD
Jia Luo, MD @jia-luo.bsky.social · 21/02/2025
Fantastic comprehensive talk on role of consolidative radiation in lung cancer treatment by colleague Dr David Kozono Great discussion regarding existing data including PORT and ongoing trials - and subsequent Q&A! @danafarber.bsky.social #lcsm #oncsky @iaslc.bsky.social
032
Jennifer A. Marks, MD @jennifermarksmd.bsky.social · 19/02/2025
Congratulations!
010
Reposted by Jennifer A. Marks, MD
JAMA @jama.com · 13/02/2025
🧵 US states that implemented abortion bans saw higher than expected infant mortality rates, with larger increases among Black infants and those in southern states, according to this analysis of US national vital statistics data from 2012–2023. ja.ma/4aVchPn #MedSky
Figure 1.  Trends in Biannual US Infant Mortality Rates, 2012-2023
11339247
Reposted by Jennifer A. Marks, MD
Tara Herrmann, PhD @tlblase.bsky.social · 03/02/2025
My philosophy for the upcoming years Darkness grows in the quiet
0106